Ryan Charles S.
Insider CIK 1624830 · BRTX Director · NTRP Chief Executive Officer, Director, 10% owner · QNCX President · APDN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2026-01-23 | 2026-01-23 | 200,000 | — | $0 | 200,000 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-23 | 7,548 | $0.13 | $981 | 7,548 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award | 2025-06-18 | 2025-06-23 | 7,548 | $1.20 | $9.1K | 130,009 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2025-01-28 | 2025-02-11 | 300,000 | — | $0 | 300,000 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | P Buy | 2024-08-20 | 2024-08-22 | 48,387 | $0.65 | $31.5K | 122,461 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-02 | 145,000 | — | $0 | 145,000 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2023-09-01 | 2023-09-06 | 545,000 | — | $0 | 545,000 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 157,918 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 150,000 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 130,680 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 40,000 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | D To issuer deriv | 2020-12-01 | 2020-12-03 | 79,097 | — | $0 | 0 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2020-11-24 | 2020-11-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2019-12-13 | 2019-12-16 | 130,680 | — | $0 | 130,680 | SEC↗ |
| APDN APPLIED DNA SCIENCES INC | A Award deriv | 2019-05-17 | 2019-05-21 | 175,435 | — | $0 | 175,435 | SEC↗ |
| BRTX BioRestorative Therapies, | D To issuer deriv | 2019-03-25 | 2019-03-25 | 15,000 | — | $0 | 0 | SEC↗ |
| BRTX BioRestorative Therapies, | D To issuer deriv | 2019-03-25 | 2019-03-25 | 20,000 | — | $0 | 0 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award deriv | 2019-03-25 | 2019-03-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award deriv | 2019-03-25 | 2019-03-25 | 46,000 | — | $0 | 46,000 | SEC↗ |
| BRTX BioRestorative Therapies, | D To issuer deriv | 2019-03-25 | 2019-03-25 | 46,000 | — | $0 | 0 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award deriv | 2019-03-25 | 2019-03-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award deriv | 2019-03-25 | 2019-03-25 | 75,000 | — | $0 | 75,000 | SEC↗ |
| BRTX BioRestorative Therapies, | D To issuer deriv | 2019-03-25 | 2019-03-25 | 75,000 | — | $0 | 0 | SEC↗ |
| BRTX BioRestorative Therapies, | D To issuer deriv | 2019-03-25 | 2019-03-25 | 100,000 | — | $0 | 0 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award deriv | 2019-03-25 | 2019-03-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2019-01-22 | 2019-01-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2018-12-14 | 2018-12-17 | 79,097 | — | $0 | 79,097 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award deriv | 2018-10-29 | 2018-10-31 | 75,000 | — | $0 | 75,000 | SEC↗ |
| APDN APPLIED DNA SCIENCES INC | A Award deriv | 2018-10-17 | 2018-10-17 | 12,778 | — | $0 | 12,778 | SEC↗ |
| APDN APPLIED DNA SCIENCES INC | D To issuer deriv | 2018-10-17 | 2018-10-17 | 12,778 | — | $0 | 0 | SEC↗ |
| APDN APPLIED DNA SCIENCES INC | A Award deriv | 2018-03-15 | 2018-03-19 | 7,204 | — | $0 | 7,204 | SEC↗ |
| APDN APPLIED DNA SCIENCES INC | A Award deriv | 2018-03-15 | 2018-03-19 | 63,919 | — | $0 | 63,919 | SEC↗ |
| NTRP Neurotrope, Inc. | A Award deriv | 2017-12-14 | 2017-12-18 | 157,918 | — | $0 | 157,918 | SEC↗ |
| APDN APPLIED DNA SCIENCES INC | A Award | 2017-06-28 | 2017-06-29 | 14,205 | $1.76 | $25.0K | 14,205 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award deriv | 2017-06-23 | 2017-06-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award deriv | 2017-03-01 | 2017-03-03 | 26,667 | — | $0 | 26,667 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award | 2017-03-01 | 2017-03-03 | 26,667 | $3.00 | $80.0K | 42,917 | SEC↗ |
| BRTX BioRestorative Therapies, | D To issuer deriv | 2017-02-14 | 2017-02-16 | 20,000 | — | $0 | 0 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award deriv | 2017-02-14 | 2017-02-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award deriv | 2017-02-14 | 2017-02-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BRTX BioRestorative Therapies, | D To issuer deriv | 2017-02-14 | 2017-02-16 | 15,000 | — | $0 | 0 | SEC↗ |
| APDN APPLIED DNA SCIENCES INC | A Award deriv | 2016-12-20 | 2016-12-22 | 44,787 | — | $0 | 44,787 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award deriv | 2016-06-10 | 2016-06-14 | 46,000 | — | $0 | 46,000 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award deriv | 2015-12-22 | 2015-12-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| APDN APPLIED DNA SCIENCES INC | A Award deriv | 2015-12-21 | 2015-12-23 | 32,455 | — | $0 | 32,455 | SEC↗ |
| BRTX BioRestorative Therapies, | P Buy deriv | 2015-12-07 | 2015-12-17 | 6,250 | — | $0 | 6,250 | SEC↗ |
| BRTX BioRestorative Therapies, | P Buy | 2015-12-07 | 2015-12-17 | 6,250 | $4.00 | $25.0K | 16,250 | SEC↗ |
| BRTX BioRestorative Therapies, | P Buy deriv | 2015-05-08 | 2015-05-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BRTX BioRestorative Therapies, | P Buy | 2015-05-08 | 2015-05-12 | 200,000 | $0.25 | $50.0K | 200,000 | SEC↗ |
| BRTX BioRestorative Therapies, | A Award deriv | 2015-04-06 | 2015-04-08 | 300,000 | — | $0 | 300,000 | SEC↗ |
| APDN APPLIED DNA SCIENCES INC | A Award deriv | 2014-12-22 | 2014-12-24 | 36,134 | — | $0 | 36,134 | SEC↗ |